ProNeurotech is a developer of neuroprotective drugs that prevent axon loss after acute injury or chronic degenerative disease.
Business Model:
Revenue: $0
Employees: 11-50
Address:
City: South San Francisco
State: California
Zip:
Country: United States
ProNeurotech is a developer of neuroprotective drugs that prevent axon loss after acute injury or chronic degenerative disease. The company&s;s business includes research in biochemistry, genetics, neurology and synthetic chemistry that drive the synthesis of the cardinal metabolite, nicotinamide adenine dinucleotide, enabling patients with neurodegenerative diseases to have access to treatment of neurologic and ocular diseases.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2018 | Venture Round | 1 | - |
The Column Group The Column Group |
2/2018 | Venture Round | 1 | - |
The Column Group The Column Group |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|